Kukje Pharma Co., Ltd. (002720.KS) KSC

4,365.00

+45(+1.04%)

Updated at December 05 03:30PM

Currency In KRW

Valuation

Market Cap103.03B
Enterprise Value123.86B
P/E Ratio13.91
PEG Ratio0.29
Price/Sales Ratio0.53
Price/Book Ratio0.95
Enterprise/Revenue0.63
Enterprise/EBITDA3.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.05

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue156.46B
Revenue/Share8,260.02
Gross Profit82.5B
EBITDA11.02B
Net Income5.21B
Diluted EPS255.64

Balance Sheet

Total Cash12.54B
Total Cash/Share617.1
Total Debt29.48B
Total Debt/Equity0.32
Current Ratio2.26
Book Value Per Share4,597.69

Price History

52-Week Change-14.91
52-Week High5,770
52-Week Low4,095
Moving Average 50 Days4,328.1
Moving Average 200 Days4,636.4

Statistics

Average Volume121,558
Shares Outstanding20.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate30
Trailing Annual Dividend Yield0.69
Payout Ratio0
Last Split Factor21:20
Last Split DateMarch 17, 2023